Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332774 · ClinicalTrials.gov registry record · Phase 3
Nevanac 3-Month Safety Study With QID Dosing
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 149
- Enrollment target
NCT00332774: Completed Phase 3 study, sponsored by Alcon Research.
NCT00332774 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 149 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00332774, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 149 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety of Nevanac 0.1% compared to Acular LS 0.4% and Vehicle in patients treated before cataract surgery and for approximately 90 days following surgery.
Interventions
- DRUG Nepafenac ophthalmic solution 0.1%
- DRUG Ketorolac Tromethamine ophthalmic solution 0.4%
- OTHER Nepafenac ophthalmic suspension vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
What the finished NCT00332774 record still lists
NCT00332774 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 3 interventions - of which Nepafenac ophthalmic solution 0.1% is the first listed.
NCT00332774 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00332774 about?
NCT00332774 is a clinical study titled "Nevanac 3-Month Safety Study With QID Dosing". The purpose of this study is to determine the safety of Nevanac 0.1% compared to Acular LS 0.4% and Vehicle in patients treated before cataract surgery and for approximately 90 days following surgery.
What is the current status of trial NCT00332774?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 149 participants. The study started on 2006-02. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00332774?
The interventions under investigation include: Nepafenac ophthalmic solution 0.1% (DRUG), Ketorolac Tromethamine ophthalmic solution 0.4% (DRUG), Nepafenac ophthalmic suspension vehicle (OTHER).
Who is sponsoring clinical trial NCT00332774?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00332774's enrollment target sits among peer trials
149 1546th of 2000 higher than 454 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia